tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

IFRX Stock Latest News

InflaRx N.V. Announces 2024 AGM Details
Company AnnouncementsInflaRx N.V. Announces 2024 AGM Details
15d ago
6K
IFRX
InflaRx Advances Anti-Inflammatory Therapeutics
PremiumCompany Announcements
InflaRx Advances Anti-Inflammatory Therapeutics
29d ago
6K
IFRX
InflaRx N.V. Targets Immuno-Dermatology Growth
PremiumCompany Announcements
InflaRx N.V. Targets Immuno-Dermatology Growth
29d ago
6K
IFRX
InflaRx announces INF904 development plans
PremiumThe Fly
InflaRx announces INF904 development plans
30d ago
IFRX
InflaRx sees cash runway into at least 2026
PremiumThe Fly
InflaRx sees cash runway into at least 2026
30d ago
IFRX
InflaRx reports 2023 EPS (EUR 0.78) vs. (EUR 0.67) last year
PremiumThe FlyInflaRx reports 2023 EPS (EUR 0.78) vs. (EUR 0.67) last year
30d ago
IFRX
InflaRx to Announce Development Plans for INF904 and 2023 Financial Results on March 21, 2024
PremiumPress Releases
InflaRx to Announce Development Plans for INF904 and 2023 Financial Results on March 21, 2024
1M ago
IFRX
IFRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
IFRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
IFRX
InflaRx appoints Medina as Head of Investor Relations
PremiumThe Fly
InflaRx appoints Medina as Head of Investor Relations
2M ago
IFRX
InflaRx price target lowered to $8 from $9 at H.C. Wainwright
PremiumThe Fly
InflaRx price target lowered to $8 from $9 at H.C. Wainwright
3M ago
IFRX
InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients
PremiumPress Releases
InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients
3M ago
IFRX
InflaRx announces initiation of its commitment program for GOHIBIC
PremiumThe Fly
InflaRx announces initiation of its commitment program for GOHIBIC
3M ago
IFRX
InflaRx Announces Positive Topline Results from the Multiple Ascending Dose (MAD) Phase I Study with C5aR Inhibitor INF904
PremiumPress ReleasesInflaRx Announces Positive Topline Results from the Multiple Ascending Dose (MAD) Phase I Study with C5aR Inhibitor INF904
4M ago
IFRX
InflaRx announces ‘positive’ topline results from MAD Phase I study of INF904
PremiumThe Fly
InflaRx announces ‘positive’ topline results from MAD Phase I study of INF904
4M ago
IFRX
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
AUTL
CYTO
InflaRx announces first patient dosed in Phase III trial
PremiumThe Fly
InflaRx announces first patient dosed in Phase III trial
6M ago
IFRX
InflaRx Announces First Patient Dosed in Phase III Trial with Vilobelimab in Pyoderma Gangrenosum
PremiumPress Releases
InflaRx Announces First Patient Dosed in Phase III Trial with Vilobelimab in Pyoderma Gangrenosum
6M ago
IFRX
InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update
PremiumPress Releases
InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update
6M ago
IFRX
InflaRx reports Q3 EPS (EUR 0.13) vs (EUR 0.18) last year
PremiumThe Fly
InflaRx reports Q3 EPS (EUR 0.13) vs (EUR 0.18) last year
6M ago
IFRX
InflaRx announces results from its SAD Phase I study with INF904
PremiumThe FlyInflaRx announces results from its SAD Phase I study with INF904
7M ago
IFRX
InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904
PremiumPress Releases
InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904
7M ago
IFRX
InflaRx’s Marketing Authorization Application (MAA) for Vilobelimab for Treatment of Critically Ill COVID-19 Patients under Review by European Medicines Agency (EMA)
PremiumPress Releases
InflaRx’s Marketing Authorization Application (MAA) for Vilobelimab for Treatment of Critically Ill COVID-19 Patients under Review by European Medicines Agency (EMA)
8M ago
IFRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >